MaaT Pharma raise €18m to advance clinical pipeline
The financing included the microbiome-focused US investor, SymBiosis, LLC, and was supported by MaaT Pharma’s existing investors Seventure Partners,...
AC Immune SA gets Lilly milestone for Alzheimers’ candidate
In only 15 months of time, AC Immune has been progressing its the small molecule Morphomer™ Tau aggregation inhibitor candidate ACI-3024 into...
HepaRegeniX: €11m for liver disease treatment
In preclinical studies, HepaRegeniX’ MKK4 inhibitor had demonstrated efficacy in liver regeneration and experimental acute and chronic liver disease...
Azafaros BV raises €25m in Series A round
The round was led by Forbion, with BioMedPartners and seed investor BioGeneration Ventures (BGV) co-investing. The Naarden-based 2018...
Novacyt inks contract on Covid-19 diagnostics
Novacyt SA ’s British molecular diagnostics division Primerdesign Ltd (Camberley) signed a global distribution agreement for its COVID-19 test with...
Sleeping sickness target deciphered
Using ultra-bright X-ray flashes, a team of researchers led by Lars Redecke from the University of Lübeck and DESY, Christian Betzel from the...